Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenue, net	$ 3,187	$ 7,000
Cost of product sold	3,521	0
Gross profit (loss)	(334)	7,000
Operating expenses:
Research and development	20,703	60,193
Selling, general and administrative	11,930	7,327
Total operating expenses	32,633	67,520
Loss from operations	(32,967)	(60,520)
Other income (expense), net	(84)	28
Net loss and comprehensive loss	$ (33,051)	$ (60,492)
Net loss per share, basic and diluted	$ (1.25)	$ (4.61)
Weighted average shares used in the calculation of net loss per share, basic and diluted	26,468,154	13,110,713
Grant [Member]
Revenue	$ 874	$ 7,000
Product revenue, net
Revenue	$ 2,313	$ 0